STOCKHOLDERS' DEFICIENCY	12 Months Ended
Dec. 31, 2018
Stockholders' Equity Note [Abstract]
STOCKHOLDERS' DEFICIENCY	Preferred Stock - The Company’s certificate of incorporation authorizes its Board to issue up to 1,000,000 shares of preferred stock. The stock is issuable in series that may vary as to certain rights and preferences, as determined upon issuance, and has a par value of $.01 per share. As of December 31, 2018, and 2017, there were no preferred shares issued or outstanding. Common Stock - On March 14, 2016, as payment of a fee under the 2016 Note Payable, the Company issued 2,500,000 shares of its common stock valued at $.015 per share or $37,500. The value is based upon the closing bid quotation of common stock on the OTC Bulletin Board on the date of the agreement. 2005 Plan - The Company’s Board and stockholders approved a stock option plans adopted in 2005, which has authority to grant options to purchase up to an aggregate of 1,030,000 common shares at December 31, 2018 (1,146,000 - 2017). 2009 Plan - During 2009, the Company’s Board approved the 2009 stock option plan, which grants options to purchase up to an aggregate of 4,000,000 common shares of which 348,000 common shares are available for grant at December 31, 2018 (578,000 - 2017). Options issued to date are nonqualified since the Company has decided not to seek stockholder approval of the 2009 Plan.

STOCKHOLDERS' DEFICIENCY

12 Months Ended

Dec. 31, 2018

Stockholders' Equity Note [Abstract]

Preferred Stock - The Company’s certificate of incorporation authorizes its Board to issue up to 1,000,000 shares of preferred stock. The stock is issuable in series that may vary as to certain rights and preferences, as determined upon issuance, and has a par value of $.01 per share. As of December 31, 2018, and 2017, there were no preferred shares issued or outstanding.

Common Stock - On March 14, 2016, as payment of a fee under the 2016 Note Payable, the Company issued 2,500,000 shares of its common stock valued at $.015 per share or $37,500. The value is based upon the closing bid quotation of common stock on the OTC Bulletin Board on the date of the agreement.

2005 Plan - The Company’s Board and stockholders approved a stock option plans adopted in 2005, which has authority to grant options to purchase up to an aggregate of 1,030,000 common shares at December 31, 2018 (1,146,000 - 2017).

2009 Plan - During 2009, the Company’s Board approved the 2009 stock option plan, which grants options to purchase up to an aggregate of 4,000,000 common shares of which 348,000 common shares are available for grant at December 31, 2018 (578,000 - 2017). Options issued to date are nonqualified since the Company has decided not to seek stockholder approval of the 2009 Plan.